YK11 (Myanabol) – 60 x 10mg Capsules

Description

YK11, also known as Myanabol, is a synthetic compound categorised as a selective androgen receptor modulator (SARM). Discovered in 2011 by Japanese researcher Yuichiro Kanno, YK11 has gained attention for its unique dual mechanism of action.

Unlike traditional SARMs that selectively target androgen receptors in muscle and bone tissues, YK11 also functions as a myostatin inhibitor. Myostatin is a protein naturally produced in the body that acts as a regulator of muscle growth. By inhibiting myostatin, YK11 allows for the promotion of muscle hypertrophy ( muscle growth) beyond what is typically achievable through natural means.

The muscle-building benefits of this compound includes:

1. Increased Muscle Mass: YK11 has been reported to promote significant gains in muscle size and mass. By inhibiting myostatin and activating androgen receptors in muscle tissue, it can stimulate muscle growth at an accelerated rate.
2. Enhanced Strength: Alongside muscle growth, YK11 is known to improve strength levels. Users often experience increased power and force output, enabling them to lift heavier weights and perform more challenging exercises.
3. Improved Muscle Definition: YK11 not only increases muscle size but also contributes to muscle hardness and definition. This results in a more sculpted and aesthetic physique, with enhanced muscle separation and detail.
4. Faster Recovery: YK11 has been reported to support faster recovery times between workouts. By reducing muscle damage and inflammation, it allows users to recover more quickly from intense training sessions, enabling them to train more frequently and with greater intensity.

It’s important to note that while this compound offers promising muscle-building benefits, its safety and long-term effects have not been thoroughly studied. As with any performance-enhancing compound, users should exercise caution, consult with a healthcare professional, and adhere to recommended dosages to minimise potential risks.

It is strongly advised researchers opt for a full PCT protocol when researching, prioritising health and safety is paramount.